Evidence map›Paper›PMID 38526073›Full record

ArticleAntimicrobial agents and chemotherapy2024

Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of

Ana Raquel Maia, Adeline Cezard, Delphine Fouquenet, Virginie Vasseur, Benoit Briard, Jean-Claude Sirard, Mustapha Si-Tahar, Virginie Hervé

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ana Raquel Maia *INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Adeline Cezard *INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.ORCID 0000-0001-8608-701X
Delphine FouquenetINSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Virginie VasseurINSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Benoit BriardINSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.
Jean-Claude SirardUniversité Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France.ORCID 0000-0001-9854-4652
Mustapha Si-Tahar *INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.ORCID 0000-0002-5792-7742
Virginie Hervé *INSERM, Centre d'Etude des Pathologies Respiratoires (CEPR), UMR 1100, Tours, France.ORCID 0000-0001-9687-0163
Université de Tours · FRCentre National de la Recherche Scientifique · FR

Funding

European Union's Horizon 2020 research and innovation programme 847786
6 · The paper itself

Abstract

The increasing prevalence of multidrug-resistant

Indexed as

Administration, IntranasalAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialFlagellinGentamicinsPseudomonas aeruginosaPseudomonas InfectionsAnimalsBacterial LoadDrug SynergismFemaleLungMiceMicrobial Sensitivity TestsToll-Like Receptor 5Anti-Bacterial AgentsFlagellinGentamicinsToll-Like Receptor 5antimicrobialflagellingentamicinmultidrug resistanceprophylacticPseudomonas aeruginosa

Identifiers

PMID38526073
PMCPMC11064517
OpenAlexW4393145658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.